Á¦8Â÷ Ç÷¾×Á¾¾ç³»°ú ¿¬¼ö°Á°¡ ´ÙÀ½°ú °°ÀÌ °³Ãֵ˴ϴÙ. ½Ã°£ : 3¿ù 30ÀÏ (Åä) ¿ÀÀü10½Ã-¿ÀÈÄ5½Ã 40ºÐ Àå¼Ò : ¼¿ï´ëÇк´¿ø ÀÓ»óÀÇÇבּ¸¼Ò ´ë°´ç
´ë»ó : Ç÷¾×Á¾¾ç³»°ú Àü¹®ÀÇ, °³¿øÀÇ, ÀüÀÓÀÇ, Àü°øÀÇ ¿¬¼öÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 6ÆòÁ¡, ´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°úºÐ°úÀü¹®ÀÇ 6ÆòÁ¡
½ÅûÁÖ¼Ò: 110-744 ¼¿ï½Ã Á¾·Î±¸ ¿¬°Çµ¿ 28 ¼¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú Tel:02-760-2199, Fax:02-742-6689, E-mail:kimty@snu.ac.kr
»çÀüµî·Ï ¸¶°¨Àº 3¿ù 9ÀÏÀ̸ç FAX ¶Ç´Â ¼¿ï´ëÇб³ Ç÷¾×Á¾¾ç³»°ú ȨÆäÀÌÁö(http://hmo.snu.ac.kr)¸¦ ÅëÇÏ¿© µî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù. »çÀüµî·Ï½Ã ½ÅûÀÎÀÇ ¼º¸íÀ» ÇÊÈ÷ ±âÀÔÇϽðí, ¾Æ·¡ÀÇ ÀºÇ౸Á·ΠÀԱݽÃÄÑ ÁֽʽÿÀ.
¿¹±ÝÁÖ:¹Ú¼±¾ç, Á¶ÈïÀºÇà:¿¬°Çµ¿ ÁöÁ¡, ±¸Á¹øÈ£:367-04-612868 ¼ö°·á : (±³Àç ¹× Áᫎ Á¦°ø) »çÀüµî·Ï: 4¸¸¿ø »çÀüµî·Ï ¸¶°¨ (2002. 3.9), ÀüÀÓÀÇ/Àü°øÀÇ: 3¸¸¿ø ÇöÀåµî·Ï: 5¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ: 4¸¸¿ø
************************************************
Ç׾Ͽä¹ýÀÇ ÃֽŠµ¿Çâ 2002 Current Issues of Chemotherapy-2002
10:00-10:10 Introduction
I. ³ëÀÎ ¾ÏȯÀÚÀÇ Ç×¾ÏÄ¡·á Overview 10:10-10:25 Biology È«¿µ¼± (Ä«Å縯ÀÇ´ë) 10:25-10:40 Geriatric evaluation ±èöȣ (¼¿ïÀÇ´ë) 10:40-10:55 Pharmacology ±èÁؼ® (°í·ÁÀÇ´ë) 10:55-11:10 Discussion
Management of Elderly Cancer Patients 11:10-11:25 Malignant lymphoma ·ù¹é·Ä (¿øÀڷº´¿ø) 11:25-11:40 Leukemia À±¼º¼ö (¼¿ïÀÇ´ë) 11:40-11:55 Lung cancer ¹Ú±ÙÄ¥ (¼º±Õ°üÀÇ´ë) 11:55-12:10 Palliative care ±è½Ã¿µ (°æÈñÀÇ´ë) 12:10-12:25 Discussion 12:25-1:30 Lunch
II. Ç׾Ͽä¹ýÀÇ ÃÖ½ÅÁö°ß New Drugs in Clinic-1 13:30-13:45 Thalidomide in cancer therapy ½Åµ¿º¹ (°¡ÃµÀÇ´ë) 13:45-14:00 Arsenic trioxide for hematologic malignancies Á¤Ã¶¿ø (¼º±Õ°üÀÇ´ë) 14:00-14:15 Temozolomide in brain tumor ¹Ú¿µÀÌ (ÇѸ²ÀÇ´ë) 14:15-14:30 Novel hormonal therapy Á¤Çöö (¿¬¼¼ÀÇ´ë) 14:30-14:45 Discussion
Antibody-Based Therapy 14:45-15:00 Her-2/neu targeted antibody ÀÓ¿µÇõ (¼º±Õ°üÀÇ´ë) 15:00-15:15 CD20 targeted antibody ¾ÈÁø¼® (ÇѸ²ÀÇ´ë) 15:15-15:30 EGFR targeted antibody ±è¿È« (°í·ÁÀÇ´ë) 15:30-15:45 Discussion
15:45-16:00 Coffee Break
Novel Approach of Chemotherapy 16:00-16:15 Pharmacogenetic-based chemotherapy ±èÅÂÀ¯ (¼¿ïÀÇ´ë) 16:15-16:30 Novel combination chemotherapy in solid tumors ¹Ú¿µ¼® (±¹¸³¾Ï¼¾ÅÍ) 16:30-16:45 Discussion
New Drugs in Clinic-2 16:45-17:00 STI571 in malignant GIST °À±±¸ (¿ï»êÀÇ´ë) 17:00-17:15 New drugs in clinical trials ¹æ¿µÁÖ (¼¿ïÀÇ´ë) 17:15-17:30 Ethics of anticancer drug approval Çã´ë¼® (¼¿ïÀÇ´ë) 17:30-17:45 Discussion
17:30-17:40 Closing remark
|